Detailed Mechanism Funding and Narrative

Years of mechanism: 2012 2013 2014 2015 2016 2017 2018 2019 2020

Details for Mechanism ID: 13580
Country/Region: Zambia
Year: 2018
Main Partner: Centre for Infectious Diseases Research in Zambia
Main Partner Program: NA
Organizational Type: NGO
Funding Agency: HHS/CDC
Total Funding: $29,783,051 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $1,208,926
Care: TB/HIV (HVTB) $2,600,000
Care: Pediatric Care and Support (PDCS) $1,000,000
Laboratory Infrastructure (HLAB) $183,403
Health Systems Strengthening (OHSS) $795,692
Biomedical Prevention: Voluntary Medical Male Circumcision (CIRC) $2,235,534
Testing: HIV Testing and Counseling (HVCT) $943,384
Sexual Prevention: Other Sexual Prevention (HVOP) $1,012,887
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $2,700,319
Treatment: Adult Treatment (HTXS) $14,648,100
Treatment: Pediatric Treatment (PDTX) $2,454,806
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_SELF 2019 67,908
HTS_SELF 10-14, Female, Directly-Assisted 2019 672
HTS_SELF 10-14, Female, Unassisted 2019 1,343
HTS_SELF 10-14, Male, Directly-Assisted 2019 672
HTS_SELF 10-14, Male, Unassisted 2019 1,343
HTS_SELF 15-19, Female, Directly-Assisted 2019 2,017
HTS_SELF 15-19, Female, Unassisted 2019 2,017
HTS_SELF 15-19, Male, Directly-Assisted 2019 1,343
HTS_SELF 15-19, Male, Unassisted 2019 1,343
HTS_SELF 20-24, Female, Directly-Assisted 2019 2,689
HTS_SELF 20-24, Female, Unassisted 2019 2,688
HTS_SELF 20-24, Male, Directly-Assisted 2019 2,689
HTS_SELF 20-24, Male, Unassisted 2019 2,689
HTS_SELF 25-29, Female, Directly-Assisted 2019 2,689
HTS_SELF 25-29, Female, Unassisted 2019 2,689
HTS_SELF 25-29, Male, Directly-Assisted 2019 2,689
HTS_SELF 25-29, Male, Unassisted 2019 2,689
HTS_SELF 30-34, Female, Directly-Assisted 2019 2,689
HTS_SELF 30-34, Female, Unassisted 2019 2,689
HTS_SELF 30-34, Male, Directly-Assisted 2019 2,689
HTS_SELF 30-34, Male, Unassisted 2019 2,689
HTS_SELF 35-39, Female, Directly-Assisted 2019 2,689
HTS_SELF 35-39, Female, Unassisted 2019 2,689
HTS_SELF 35-39, Male, Directly-Assisted 2019 2,689
HTS_SELF 35-39, Male, Unassisted 2019 2,689
HTS_SELF 40-49, Female, Directly-Assisted 2019 2,689
HTS_SELF 40-49, Female, Unassisted 2019 2,689
HTS_SELF 40-49, Male, Directly-Assisted 2019 2,689
HTS_SELF 40-49, Male, Unassisted 2019 2,687
HTS_SELF 50+, Female, Directly-Assisted 2019 672
HTS_SELF 50+, Female, Unassisted 2019 665
HTS_SELF 50+, Male, Directly-Assisted 2019 672
HTS_SELF 50+, Male, Unassisted 2019 686
HTS_SELF Directly-Assisted 2019 33,624
HTS_SELF FSW, Directly-Assisted 2019 20,159
HTS_SELF FSW, Unassisted 2019 22,698
HTS_SELF MSM, Directly-Assisted 2019 10,082
HTS_SELF MSM, Unassisted 2019 12,911
HTS_SELF Unassisted 2019 34,284
HTS_SELF Unassisted - Other 2019 8,572
HTS_SELF Unassisted - Self 2019 17,140
HTS_SELF Unassisted - Sex Partner 2019 8,572
HTS_TST <5, Unknown Sex, Negative 2019 868
HTS_TST 1-9, Unknown Sex, Negative 2019 678
HTS_TST 10-14, Female, Negative 2019 110
HTS_TST 10-14, Female, Negative 2019 107
HTS_TST 10-14, Male, Negative 2019 79
HTS_TST 10-14, Male, Negative 2019 53
HTS_TST 15-19, Female, Negative 2019 965
HTS_TST 15-19, Female, Negative 2019 991
HTS_TST 15-19, Male, Negative 2019 239
HTS_TST 15-19, Male, Negative 2019 263
HTS_TST 20-24, Female, Negative 2019 827
HTS_TST 20-24, Female, Negative 2019 882
HTS_TST 20-24, Male, Negative 2019 415
HTS_TST 20-24, Male, Negative 2019 523
HTS_TST 25-29, Female, Negative 2019 7,003
HTS_TST 25-29, Female, Negative 2019 230
HTS_TST 25-29, Female, Negative 2019 21,383
HTS_TST 25-29, Female, Negative 2019 438
HTS_TST 25-29, Female, Negative 2019 318
HTS_TST 25-29, Female, Negative 2019 7,016
HTS_TST 25-29, Female, Negative 2019 777
HTS_TST 25-29, Female, Negative 2019 500
HTS_TST 25-29, Female, Negative 2019 1,402
HTS_TST 25-29, Female, Negative 2019 614
HTS_TST 25-29, Female, Negative 2019 284
HTS_TST 25-29, Female, Negative 2019 936
HTS_TST 25-29, Male, Negative 2019 7,017
HTS_TST 25-29, Male, Negative 2019 253
HTS_TST 25-29, Male, Negative 2019 445
HTS_TST 25-29, Male, Negative 2019 331
HTS_TST 25-29, Male, Negative 2019 7,305
HTS_TST 25-29, Male, Negative 2019 777
HTS_TST 25-29, Male, Negative 2019 2,107
HTS_TST 25-29, Male, Negative 2019 542
HTS_TST 25-29, Male, Negative 2019 1,293
HTS_TST 25-29, Male, Negative 2019 642
HTS_TST 25-29, Male, Negative 2019 293
HTS_TST 25-29, Male, Negative 2019 937
HTS_TST 30-34, Female, Negative 2019 7,003
HTS_TST 30-34, Female, Negative 2019 230
HTS_TST 30-34, Female, Negative 2019 16,042
HTS_TST 30-34, Female, Negative 2019 428
HTS_TST 30-34, Female, Negative 2019 318
HTS_TST 30-34, Female, Negative 2019 7,016
HTS_TST 30-34, Female, Negative 2019 777
HTS_TST 30-34, Female, Negative 2019 500
HTS_TST 30-34, Female, Negative 2019 1,380
HTS_TST 30-34, Female, Negative 2019 614
HTS_TST 30-34, Female, Negative 2019 304
HTS_TST 30-34, Female, Negative 2019 936
HTS_TST 30-34, Male, Negative 2019 7,017
HTS_TST 30-34, Male, Negative 2019 253
HTS_TST 30-34, Male, Negative 2019 445
HTS_TST 30-34, Male, Negative 2019 331
HTS_TST 30-34, Male, Negative 2019 7,305
HTS_TST 30-34, Male, Negative 2019 777
HTS_TST 30-34, Male, Negative 2019 2,107
HTS_TST 30-34, Male, Negative 2019 542
HTS_TST 30-34, Male, Negative 2019 1,303
HTS_TST 30-34, Male, Negative 2019 642
HTS_TST 30-34, Male, Negative 2019 293
HTS_TST 30-34, Male, Negative 2019 977
HTS_TST 35-39, Female, Negative 2019 7,003
HTS_TST 35-39, Female, Negative 2019 230
HTS_TST 35-39, Female, Negative 2019 10,699
HTS_TST 35-39, Female, Negative 2019 428
HTS_TST 35-39, Female, Negative 2019 318
HTS_TST 35-39, Female, Negative 2019 7,016
HTS_TST 35-39, Female, Negative 2019 777
HTS_TST 35-39, Female, Negative 2019 500
HTS_TST 35-39, Female, Negative 2019 1,380
HTS_TST 35-39, Female, Negative 2019 614
HTS_TST 35-39, Female, Negative 2019 284
HTS_TST 35-39, Female, Negative 2019 936
HTS_TST 35-39, Male, Negative 2019 7,017
HTS_TST 35-39, Male, Negative 2019 253
HTS_TST 35-39, Male, Negative 2019 445
HTS_TST 35-39, Male, Negative 2019 331
HTS_TST 35-39, Male, Negative 2019 7,305
HTS_TST 35-39, Male, Negative 2019 777
HTS_TST 35-39, Male, Negative 2019 2,107
HTS_TST 35-39, Male, Negative 2019 542
HTS_TST 35-39, Male, Negative 2019 1,293
HTS_TST 35-39, Male, Negative 2019 642
HTS_TST 35-39, Male, Negative 2019 313
HTS_TST 35-39, Male, Negative 2019 937
HTS_TST 40-49, Female, Negative 2019 7,003
HTS_TST 40-49, Female, Negative 2019 230
HTS_TST 40-49, Female, Negative 2019 5,344
HTS_TST 40-49, Female, Negative 2019 428
HTS_TST 40-49, Female, Negative 2019 318
HTS_TST 40-49, Female, Negative 2019 7,016
HTS_TST 40-49, Female, Negative 2019 777
HTS_TST 40-49, Female, Negative 2019 500
HTS_TST 40-49, Female, Negative 2019 1,390
HTS_TST 40-49, Female, Negative 2019 614
HTS_TST 40-49, Female, Negative 2019 284
HTS_TST 40-49, Female, Negative 2019 936
HTS_TST 40-49, Male, Negative 2019 7,017
HTS_TST 40-49, Male, Negative 2019 253
HTS_TST 40-49, Male, Negative 2019 445
HTS_TST 40-49, Male, Negative 2019 331
HTS_TST 40-49, Male, Negative 2019 7,305
HTS_TST 40-49, Male, Negative 2019 777
HTS_TST 40-49, Male, Negative 2019 2,107
HTS_TST 40-49, Male, Negative 2019 542
HTS_TST 40-49, Male, Negative 2019 1,293
HTS_TST 40-49, Male, Negative 2019 642
HTS_TST 40-49, Male, Negative 2019 293
HTS_TST 40-49, Male, Negative 2019 967
HTS_TST 50+, Female, Negative 2019 593
HTS_TST 50+, Female, Negative 2019 713
HTS_TST 50+, Male, Negative 2019 566
HTS_TST 50+, Male, Negative 2019 699
HTS_TST By Key Population: FSW, Negative 2019 2,454
HTS_TST By Key Population: MSM, Negative 2019 173
HTS_TST By Key Population: People in prisons and other enclosed settings, Negative 2019 534
HTS_TST By Key Population: TG, Negative 2019 33
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2019 638,200
HTS_TST Service Delivery Point (Community) Index Mod: 1-9, Negative 2019 3,683
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Female, Negative 2019 78
HTS_TST Service Delivery Point (Community) Index Mod: 10-14, Male, Negative 2019 280
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Female, Negative 2019 1,783
HTS_TST Service Delivery Point (Community) Index Mod: 15-19, Male, Negative 2019 644
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Female, Negative 2019 1,614
HTS_TST Service Delivery Point (Community) Index Mod: 20-24, Male, Negative 2019 1,115
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Female, Negative 2019 1,159
HTS_TST Service Delivery Point (Community) Index Mod: 50+, Male, Negative 2019 958
HTS_TST Service Delivery Point (Community) Mobile Testing: 1-9, Negative 2019 1,288
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Female, Negative 2019 690
HTS_TST Service Delivery Point (Community) Mobile Testing: 10-14, Male, Negative 2019 148
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Female, Negative 2019 597
HTS_TST Service Delivery Point (Community) Mobile Testing: 15-19, Male, Negative 2019 150
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Female, Negative 2019 490
HTS_TST Service Delivery Point (Community) Mobile Testing: 20-24, Male, Negative 2019 362
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Female, Negative 2019 377
HTS_TST Service Delivery Point (Community) Mobile Testing: 50+, Male, Negative 2019 380
HTS_TST Service Delivery Point (Community) Other: 15-19, Female, Negative 2019 458
HTS_TST Service Delivery Point (Community) Other: 15-19, Male, Negative 2019 123
HTS_TST Service Delivery Point (Community) Other: 20-24, Female, Negative 2019 419
HTS_TST Service Delivery Point (Community) Other: 20-24, Male, Negative 2019 243
HTS_TST Service Delivery Point (Community) Other: 50+, Female, Negative 2019 328
HTS_TST Service Delivery Point (Community) Other: 50+, Male, Negative 2019 329
HTS_TST Service Delivery Point (Community) VCT Mod: 1-9, Negative 2019 737
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Female, Negative 2019 115
HTS_TST Service Delivery Point (Community) VCT Mod: 10-14, Male, Negative 2019 62
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Female, Negative 2019 1,683
HTS_TST Service Delivery Point (Community) VCT Mod: 15-19, Male, Negative 2019 516
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Female, Negative 2019 1,552
HTS_TST Service Delivery Point (Community) VCT Mod: 20-24, Male, Negative 2019 777
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Female, Negative 2019 1,164
HTS_TST Service Delivery Point (Community) VCT Mod: 50+, Male, Negative 2019 1,036
HTS_TST Service Delivery Point (Facility) ANC: 10-14, Negative 2019 542
HTS_TST Service Delivery Point (Facility) ANC: 15-19, Negative 2019 22,351
HTS_TST Service Delivery Point (Facility) ANC: 20-24, Negative 2019 30,879
HTS_TST Service Delivery Point (Facility) ANC: 50+, Negative 2019 1,844
HTS_TST Service Delivery Point (Facility) Index: 1-9, Negative 2019 4,328
HTS_TST Service Delivery Point (Facility) Index: 10-14, Female, Negative 2019 698
HTS_TST Service Delivery Point (Facility) Index: 10-14, Male, Negative 2019 375
HTS_TST Service Delivery Point (Facility) Index: 15-19, Female, Negative 2019 2,296
HTS_TST Service Delivery Point (Facility) Index: 15-19, Male, Negative 2019 1,046
HTS_TST Service Delivery Point (Facility) Index: 20-24, Female, Negative 2019 2,357
HTS_TST Service Delivery Point (Facility) Index: 20-24, Male, Negative 2019 1,455
HTS_TST Service Delivery Point (Facility) Index: 50+, Female, Negative 2019 2,050
HTS_TST Service Delivery Point (Facility) Index: 50+, Male, Negative 2019 1,417
HTS_TST Service Delivery Point (Facility) Inpatient: 1-9, Negative 2019 8,151
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Female, Negative 2019 1,307
HTS_TST Service Delivery Point (Facility) Inpatient: 10-14, Male, Negative 2019 722
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Female, Negative 2019 1,259
HTS_TST Service Delivery Point (Facility) Inpatient: 15-19, Male, Negative 2019 331
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Female, Negative 2019 1,107
HTS_TST Service Delivery Point (Facility) Inpatient: 20-24, Male, Negative 2019 677
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Female, Negative 2019 877
HTS_TST Service Delivery Point (Facility) Inpatient: 50+, Male, Negative 2019 833
HTS_TST Service Delivery Point (Facility) Other PITC: 1-9, Negative 2019 50,148
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Female, Negative 2019 11,005
HTS_TST Service Delivery Point (Facility) Other PITC: 10-14, Male, Negative 2019 5,970
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Female, Negative 2019 15,233
HTS_TST Service Delivery Point (Facility) Other PITC: 15-19, Male, Negative 2019 3,845
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Female, Negative 2019 12,955
HTS_TST Service Delivery Point (Facility) Other PITC: 20-24, Male, Negative 2019 7,386
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Female, Negative 2019 9,147
HTS_TST Service Delivery Point (Facility) Other PITC: 50+, Male, Negative 2019 8,688
HTS_TST Service Delivery Point (Facility) Pediatric : <5 Negative 2019 17,000
HTS_TST Service Delivery Point (Facility) TB: 15-19, Female, Negative 2019 367
HTS_TST Service Delivery Point (Facility) TB: 15-19, Male, Negative 2019 170
HTS_TST Service Delivery Point (Facility) TB: 20-24, Female, Negative 2019 336
HTS_TST Service Delivery Point (Facility) TB: 20-24, Male, Negative 2019 367
HTS_TST Service Delivery Point (Facility) TB: 50+, Female, Negative 2019 427
HTS_TST Service Delivery Point (Facility) TB: 50+, Male, Negative 2019 889
HTS_TST Service Delivery Point (Facility) VCT: 1-9, Negative 2019 19,720
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Female, Negative 2019 3,207
HTS_TST Service Delivery Point (Facility) VCT: 10-14, Male, Negative 2019 1,763
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Female, Negative 2019 14,367
HTS_TST Service Delivery Point (Facility) VCT: 15-19, Male, Negative 2019 3,849
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Female, Negative 2019 12,299
HTS_TST Service Delivery Point (Facility) VCT: 20-24, Male, Negative 2019 7,385
HTS_TST Service Delivery Point (Facility) VCT: 50+, Female, Negative 2019 9,509
HTS_TST Service Delivery Point (Facility) VCT: 50+, Male, Negative 2019 9,197
HTS_TST Service Delivery Point (Facility) VMMC: 10-14, Negative 2019 1,744
HTS_TST Service Delivery Point (Facility) VMMC: 15-19, Negative 2019 9,703
HTS_TST Service Delivery Point (Facility) VMMC: 20-24, Negative 2019 9,635
HTS_TST Service Delivery Point (Facility) VMMC: 50+, Negative 2019 3,192
HTS_TST_POS <5, Unknown Sex, Positive 2019 173
HTS_TST_POS 1-9, Unknown Sex, Positive 2019 10
HTS_TST_POS 10-14, Female, Positive 2019 29
HTS_TST_POS 10-14, Male, Positive 2019 9
HTS_TST_POS 15-19, Female, Positive 2019 55
HTS_TST_POS 15-19, Female, Positive 2019 26
HTS_TST_POS 15-19, Male, Positive 2019 9
HTS_TST_POS 15-19, Male, Positive 2019 3
HTS_TST_POS 20-24, Female, Positive 2019 56
HTS_TST_POS 20-24, Female, Positive 2019 16
HTS_TST_POS 20-24, Male, Positive 2019 82
HTS_TST_POS 20-24, Male, Positive 2019 1
HTS_TST_POS 25-29, Female, Positive 2019 548
HTS_TST_POS 25-29, Female, Positive 2019 24
HTS_TST_POS 25-29, Female, Positive 2019 1,434
HTS_TST_POS 25-29, Female, Positive 2019 50
HTS_TST_POS 25-29, Female, Positive 2019 154
HTS_TST_POS 25-29, Female, Positive 2019 518
HTS_TST_POS 25-29, Female, Positive 2019 68
HTS_TST_POS 25-29, Female, Positive 2019 8
HTS_TST_POS 25-29, Female, Positive 2019 462
HTS_TST_POS 25-29, Female, Positive 2019 68
HTS_TST_POS 25-29, Female, Positive 2019 44
HTS_TST_POS 25-29, Female, Positive 2019 310
HTS_TST_POS 25-29, Male, Positive 2019 1,073
HTS_TST_POS 25-29, Male, Positive 2019 18
HTS_TST_POS 25-29, Male, Positive 2019 68
HTS_TST_POS 25-29, Male, Positive 2019 171
HTS_TST_POS 25-29, Male, Positive 2019 750
HTS_TST_POS 25-29, Male, Positive 2019 91
HTS_TST_POS 25-29, Male, Positive 2019 20
HTS_TST_POS 25-29, Male, Positive 2019 4
HTS_TST_POS 25-29, Male, Positive 2019 631
HTS_TST_POS 25-29, Male, Positive 2019 80
HTS_TST_POS 25-29, Male, Positive 2019 65
HTS_TST_POS 25-29, Male, Positive 2019 374
HTS_TST_POS 30-34, Female, Positive 2019 548
HTS_TST_POS 30-34, Female, Positive 2019 24
HTS_TST_POS 30-34, Female, Positive 2019 1,075
HTS_TST_POS 30-34, Female, Positive 2019 50
HTS_TST_POS 30-34, Female, Positive 2019 154
HTS_TST_POS 30-34, Female, Positive 2019 518
HTS_TST_POS 30-34, Female, Positive 2019 78
HTS_TST_POS 30-34, Female, Positive 2019 8
HTS_TST_POS 30-34, Female, Positive 2019 462
HTS_TST_POS 30-34, Female, Positive 2019 68
HTS_TST_POS 30-34, Female, Positive 2019 34
HTS_TST_POS 30-34, Female, Positive 2019 310
HTS_TST_POS 30-34, Male, Positive 2019 1,073
HTS_TST_POS 30-34, Male, Positive 2019 18
HTS_TST_POS 30-34, Male, Positive 2019 68
HTS_TST_POS 30-34, Male, Positive 2019 171
HTS_TST_POS 30-34, Male, Positive 2019 750
HTS_TST_POS 30-34, Male, Positive 2019 101
HTS_TST_POS 30-34, Male, Positive 2019 20
HTS_TST_POS 30-34, Male, Positive 2019 4
HTS_TST_POS 30-34, Male, Positive 2019 631
HTS_TST_POS 30-34, Male, Positive 2019 80
HTS_TST_POS 30-34, Male, Positive 2019 49
HTS_TST_POS 30-34, Male, Positive 2019 403
HTS_TST_POS 35-39, Female, Positive 2019 548
HTS_TST_POS 35-39, Female, Positive 2019 24
HTS_TST_POS 35-39, Female, Positive 2019 716
HTS_TST_POS 35-39, Female, Positive 2019 50
HTS_TST_POS 35-39, Female, Positive 2019 154
HTS_TST_POS 35-39, Female, Positive 2019 518
HTS_TST_POS 35-39, Female, Positive 2019 68
HTS_TST_POS 35-39, Female, Positive 2019 8
HTS_TST_POS 35-39, Female, Positive 2019 462
HTS_TST_POS 35-39, Female, Positive 2019 68
HTS_TST_POS 35-39, Female, Positive 2019 54
HTS_TST_POS 35-39, Female, Positive 2019 310
HTS_TST_POS 35-39, Male, Positive 2019 1,073
HTS_TST_POS 35-39, Male, Positive 2019 18
HTS_TST_POS 35-39, Male, Positive 2019 68
HTS_TST_POS 35-39, Male, Positive 2019 171
HTS_TST_POS 35-39, Male, Positive 2019 750
HTS_TST_POS 35-39, Male, Positive 2019 113
HTS_TST_POS 35-39, Male, Positive 2019 20
HTS_TST_POS 35-39, Male, Positive 2019 4
HTS_TST_POS 35-39, Male, Positive 2019 631
HTS_TST_POS 35-39, Male, Positive 2019 80
HTS_TST_POS 35-39, Male, Positive 2019 49
HTS_TST_POS 35-39, Male, Positive 2019 445
HTS_TST_POS 40-49, Female, Positive 2019 548
HTS_TST_POS 40-49, Female, Positive 2019 24
HTS_TST_POS 40-49, Female, Positive 2019 350
HTS_TST_POS 40-49, Female, Positive 2019 50
HTS_TST_POS 40-49, Female, Positive 2019 154
HTS_TST_POS 40-49, Female, Positive 2019 518
HTS_TST_POS 40-49, Female, Positive 2019 68
HTS_TST_POS 40-49, Female, Positive 2019 8
HTS_TST_POS 40-49, Female, Positive 2019 462
HTS_TST_POS 40-49, Female, Positive 2019 68
HTS_TST_POS 40-49, Female, Positive 2019 34
HTS_TST_POS 40-49, Female, Positive 2019 310
HTS_TST_POS 40-49, Male, Positive 2019 1,073
HTS_TST_POS 40-49, Male, Positive 2019 18
HTS_TST_POS 40-49, Male, Positive 2019 68
HTS_TST_POS 40-49, Male, Positive 2019 171
HTS_TST_POS 40-49, Male, Positive 2019 750
HTS_TST_POS 40-49, Male, Positive 2019 91
HTS_TST_POS 40-49, Male, Positive 2019 20
HTS_TST_POS 40-49, Male, Positive 2019 4
HTS_TST_POS 40-49, Male, Positive 2019 631
HTS_TST_POS 40-49, Male, Positive 2019 80
HTS_TST_POS 40-49, Male, Positive 2019 49
HTS_TST_POS 40-49, Male, Positive 2019 374
HTS_TST_POS 50+, Female, Positive 2019 73
HTS_TST_POS 50+, Female, Positive 2019 1
HTS_TST_POS 50+, Male, Positive 2019 110
HTS_TST_POS 50+, Male, Positive 2019 13
HTS_TST_POS By Key Population: FSW, Positive 2019 266
HTS_TST_POS By Key Population: MSM, Positive 2019 19
HTS_TST_POS By Key Population: People in prisons and other enclosed settings, Positive 2019 135
HTS_TST_POS By Key Population: TG, Positive 2019 7
HTS_TST_POS Service Delivery Point (Community) Index Mod: 1-9, Positive 2019 255
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Female, Positive 2019 19
HTS_TST_POS Service Delivery Point (Community) Index Mod: 10-14, Male, Positive 2019 24
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Female, Positive 2019 227
HTS_TST_POS Service Delivery Point (Community) Index Mod: 15-19, Male, Positive 2019 155
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Female, Positive 2019 323
HTS_TST_POS Service Delivery Point (Community) Index Mod: 20-24, Male, Positive 2019 272
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Female, Positive 2019 482
HTS_TST_POS Service Delivery Point (Community) Index Mod: 50+, Male, Positive 2019 750
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 1-9, Positive 2019 27
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 10-14, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Female, Positive 2019 20
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 15-19, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Female, Positive 2019 62
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 20-24, Male, Positive 2019 43
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Female, Positive 2019 47
HTS_TST_POS Service Delivery Point (Community) Mobile Testing: 50+, Male, Positive 2019 47
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Female, Positive 2019 32
HTS_TST_POS Service Delivery Point (Community) Other: 15-19, Male, Positive 2019 10
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Other: 20-24, Male, Positive 2019 18
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Female, Positive 2019 16
HTS_TST_POS Service Delivery Point (Community) Other: 50+, Male, Positive 2019 17
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 1-9, Positive 2019 19
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 10-14, Female, Positive 2019 5
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 15-19, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Female, Positive 2019 142
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 20-24, Male, Positive 2019 68
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Female, Positive 2019 91
HTS_TST_POS Service Delivery Point (Community) VCT Mod: 50+, Male, Positive 2019 91
HTS_TST_POS Service Delivery Point (Facility) ANC: 10-14, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) ANC: 15-19, Positive 2019 1,460
HTS_TST_POS Service Delivery Point (Facility) ANC: 20-24, Positive 2019 2,047
HTS_TST_POS Service Delivery Point (Facility) ANC: 50+, Positive 2019 124
HTS_TST_POS Service Delivery Point (Facility) Index: 1-9, Positive 2019 272
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Female, Positive 2019 39
HTS_TST_POS Service Delivery Point (Facility) Index: 10-14, Male, Positive 2019 19
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Female, Positive 2019 225
HTS_TST_POS Service Delivery Point (Facility) Index: 15-19, Male, Positive 2019 188
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Female, Positive 2019 283
HTS_TST_POS Service Delivery Point (Facility) Index: 20-24, Male, Positive 2019 397
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Female, Positive 2019 593
HTS_TST_POS Service Delivery Point (Facility) Index: 50+, Male, Positive 2019 923
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 1-9, Positive 2019 151
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Female, Positive 2019 25
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 10-14, Male, Positive 2019 6
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Female, Positive 2019 68
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 15-19, Male, Positive 2019 32
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Female, Positive 2019 72
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 20-24, Male, Positive 2019 23
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Female, Positive 2019 48
HTS_TST_POS Service Delivery Point (Facility) Inpatient: 50+, Male, Positive 2019 98
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 1-9, Positive 2019 1,212
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Female, Positive 2019 99
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 10-14, Male, Positive 2019 52
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Female, Positive 2019 248
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 15-19, Male, Positive 2019 140
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Female, Positive 2019 350
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 20-24, Male, Positive 2019 535
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Female, Positive 2019 732
HTS_TST_POS Service Delivery Point (Facility) Other PITC: 50+, Male, Positive 2019 1,258
HTS_TST_POS Service Delivery Point (Facility) Pediatric : <5 Positive 2019 349
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Female, Positive 2019 62
HTS_TST_POS Service Delivery Point (Facility) TB: 15-19, Male, Positive 2019 74
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Female, Positive 2019 112
HTS_TST_POS Service Delivery Point (Facility) TB: 20-24, Male, Positive 2019 117
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Female, Positive 2019 205
HTS_TST_POS Service Delivery Point (Facility) TB: 50+, Male, Positive 2019 597
HTS_TST_POS Service Delivery Point (Facility) VCT: 1-9, Positive 2019 406
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Female, Positive 2019 78
HTS_TST_POS Service Delivery Point (Facility) VCT: 10-14, Male, Positive 2019 12
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Female, Positive 2019 375
HTS_TST_POS Service Delivery Point (Facility) VCT: 15-19, Male, Positive 2019 122
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Female, Positive 2019 726
HTS_TST_POS Service Delivery Point (Facility) VCT: 20-24, Male, Positive 2019 344
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Female, Positive 2019 704
HTS_TST_POS Service Delivery Point (Facility) VCT: 50+, Male, Positive 2019 1,103
HTS_TST_POS Service Delivery Point (Facility) VMMC: 10-14, Positive 2019 14
HTS_TST_POS Service Delivery Point (Facility) VMMC: 15-19, Positive 2019 95
HTS_TST_POS Service Delivery Point (Facility) VMMC: 20-24, Positive 2019 115
HTS_TST_POS Service Delivery Point (Facility) VMMC: 50+, Positive 2019 35
KP_PREV By key population type: Female sex workers (FSW) (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 2,567
KP_PREV By key population type: Men who have sex with men who are NOT sex workers (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 500
KP_PREV By key population type: People in prisons and enclosed settings (Numerator: Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required) 2019 281
KP_PREV Number of key populations reached with individual and/or small group level HIV preventive interventions that are based on evidence and/or meet the minimum standards required 2019 3,348
PMTCT_ART Already on ART at beginning of current pregnancy 2019 11,022
PMTCT_ART New on ART 2019 9,019
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2019 20,041
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 125,724
PMTCT_EID By infants who received a virologic test within 2 months of birth 2019 16,025
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2019 4,016
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2019 20,041
PMTCT_EID Sum of Infant Age disaggregates 2019 20,041
PMTCT_STAT 25-29, Female 2019 32,248
PMTCT_STAT 25-29, Female, Known at Entry Positive 2019 3,000
PMTCT_STAT 25-29, Female, Newly Identified Negative 2019 27,251
PMTCT_STAT 25-29, Female, Newly Identified Positive 2019 1,995
PMTCT_STAT 30-34, Female 2019 31,249
PMTCT_STAT 30-34, Female, Known at Entry Positive 2019 3,000
PMTCT_STAT 30-34, Female, Newly Identified Negative 2019 26,816
PMTCT_STAT 30-34, Female, Newly Identified Positive 2019 1,428
PMTCT_STAT 35-39, Female 2019 20,295
PMTCT_STAT 35-39, Female, Known at Entry Positive 2019 2,396
PMTCT_STAT 35-39, Female, Newly Identified Negative 2019 16,385
PMTCT_STAT 35-39, Female, Newly Identified Positive 2019 1,514
PMTCT_STAT 40-49, Female 2019 15,164
PMTCT_STAT 40-49, Female, Known at Entry Positive 2019 469
PMTCT_STAT 40-49, Female, Newly Identified Negative 2019 12,801
PMTCT_STAT 40-49, Female, Newly Identified Positive 2019 1,905
PMTCT_STAT By Age (Numerator): 15-19 2019 367
PMTCT_STAT By Age (Numerator): 20-24 2019 26,401
PMTCT_STAT By Number of known positives: 15-19 2019 44
PMTCT_STAT By Number of known positives: 20-24 2019 2,113
PMTCT_STAT By Number of new negative: 15-19 2019 173
PMTCT_STAT By Number of new negative: 20-24 2019 22,257
PMTCT_STAT By Number of new positives: 15-19 2019 150
PMTCT_STAT By Number of new positives: 20-24 2019 2,027
PMTCT_STAT Number of new ANC and L&D clients 2019 136,725
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2019 125,724
PMTCT_STAT_den 25-29, Female 2019 31,372
PMTCT_STAT_den 30-34, Female 2019 20,463
PMTCT_STAT_den 35-39, Female 2019 20,463
PMTCT_STAT_den By Age (Denominator): <15-19 2019 27,288
PMTCT_STAT_den By Age (Denominator): 10-14 2019 195
PMTCT_STAT_den By Age (Denominator): 20-24 2019 36,899
PMTCT_STAT_den By Age (Denominator): 50+ 2019 45
PP_PREV 25-29, Female 2019 2,639
PP_PREV 25-29, Male 2019 1,448
PP_PREV 30-34, Female 2019 1,638
PP_PREV 30-34, Male 2019 1,581
PP_PREV 35-39, Female 2019 1,599
PP_PREV 35-39, Male 2019 1,581
PP_PREV 40-49, Female 2019 1,623
PP_PREV 40-49, Male 2019 1,589
PP_PREV Age/sex: 10-14 Female 2019 1,417
PP_PREV Age/sex: 10-14 Male 2019 1,353
PP_PREV Age/sex: 15-19 Female 2019 1,416
PP_PREV Age/sex: 15-19 Male 2019 1,414
PP_PREV Age/sex: 20-24 Female 2019 5,882
PP_PREV Age/sex: 20-24 Male 2019 2,864
PP_PREV Age/sex: 50+ Female 2019 163
PP_PREV Age/sex: 50+ Male 2019 145
PP_PREV Number of the target population who completed a standardized HIV prevention intervention including the minimum components during the reporting period 2019 28,352
PP_PREV Sum of Age/Sex disaggregates 2019 14,654
PrEP_NEW 25-29, Female 2019 200
PrEP_NEW 25-29, Male 2019 329
PrEP_NEW 30-34, Female 2019 299
PrEP_NEW 30-34, Male 2019 60
PrEP_NEW 35-39, Female 2019 60
PrEP_NEW 35-39, Male 2019 12
PrEP_NEW 40-49, Female 2019 12
PrEP_NEW Female 20-24 2019 200
PrEP_NEW FSW 2019 694
PrEP_NEW MSM 2019 150
PrEP_NEW Number of individuals who have been newly enrolled on oral antiretroviral pre-exposure prophylaxis (PrEP) in the reporting period to prevent HIV infection 2019 1,172
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 335
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 3,972
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 256
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2019 2,707
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2019 7,316
TB_PREV By Age/Sex (Numerator): <15, Female 2019 908
TB_PREV By Age/Sex (Numerator): <15, Male 2019 304
TB_PREV By Age/Sex (Numerator): 15+, Female 2019 11,195
TB_PREV By Age/Sex (Numerator): 15+, Male 2019 11,792
TB_PREV IPT, Life-long ART, New, Positive 2019 24,199
TB_PREV The number of ART patients who completed a course of TB preventive therapy or at least 6 months of Isoniazid Preventive Therapy (IPT) during the reporting period 2019 24,199
TB_PREV The number of ART patients who were newly started on TB preventive therapy (including those who newly started on TB preventive therapy in this reporting period and those who started in the previous reporting period but had not been reported as they did not fulfill the minimum requirements for the previous reporting period) 2019 40,597
TB_PREV_den By Age/Sex (Denominator): <15, Female 2019 1,141
TB_PREV_den By Age/Sex (Denominator): <15, Male 2019 970
TB_PREV_den By Age/Sex (Denominator): 15+, Female 2019 23,233
TB_PREV_den By Age/Sex (Denominator): 15+, Male 2019 15,253
TB_PREV_den IPT, Life-long ART, New, Positive 2019 40,597
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 207
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 4,371
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 261
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2019 8,482
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2019 13,321
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2019 13,321
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 207
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 4,371
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 261
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2019 8,482
TX_CURR 25-29, Female, Positive 2019 25,633
TX_CURR 25-29, Male, Positive 2019 9,883
TX_CURR 30-34, Female, Positive 2019 29,554
TX_CURR 30-34, Male, Positive 2019 16,480
TX_CURR 35-39, Female, Positive 2019 29,634
TX_CURR 35-39, Male, Positive 2019 23,232
TX_CURR 40-49, Female, Positive 2019 41,507
TX_CURR 40-49, Male, Positive 2019 46,189
TX_CURR Age/Sex: <1 2019 4,256
TX_CURR Age/Sex: <1-9 2019 8,345
TX_CURR Age/Sex: 10-14 Female 2019 3,908
TX_CURR Age/Sex: 10-14 Male 2019 2,229
TX_CURR Age/Sex: 15-19 Female 2019 7,438
TX_CURR Age/Sex: 15-19 Male 2019 5,277
TX_CURR Age/Sex: 20-24 Female 2019 16,546
TX_CURR Age/Sex: 20-24 Male 2019 5,279
TX_CURR Age/Sex: 50+ Female 2019 25,310
TX_CURR Age/Sex: 50+ Male 2019 18,176
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2019 318,876
TX_CURR Sum of age/sex disaggregates 2019 12,715
TX_NEW 25-29, Female, Positive 2019 1,926
TX_NEW 25-29, Male, Positive 2019 1,264
TX_NEW 30-34, Female, Positive 2019 2,309
TX_NEW 30-34, Male, Positive 2019 1,883
TX_NEW 35-39, Female, Positive 2019 2,541
TX_NEW 35-39, Male, Positive 2019 2,727
TX_NEW 40-49, Female, Positive 2019 3,941
TX_NEW 40-49, Male, Positive 2019 5,547
TX_NEW Breastfeeding status 2019 10,884
TX_NEW By Age/Sex: <1 2019 44
TX_NEW By Age/Sex: 1-9 2019 3,361
TX_NEW By Age/Sex: 10-14 Female 2019 254
TX_NEW By Age/Sex: 10-14 Male 2019 617
TX_NEW By Age/Sex: 15-19 Female 2019 1,007
TX_NEW By Age/Sex: 15-19 Male 2019 1,441
TX_NEW By Age/Sex: 20-24 Female 2019 926
TX_NEW By Age/Sex: 20-24 Male 2019 1,377
TX_NEW By Age/Sex: 50+ Female 2019 5,757
TX_NEW By Age/Sex: 50+ Male 2019 8,594
TX_NEW FSW 2019 718
TX_NEW MSM 2019 554
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2019 45,516
TX_NEW Pregnancy status 2019 6,746
TX_NEW Sum of Age/Sex disaggregates 2019 19,973
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2019 317,074
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2019 10,770
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2019 8,598
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2019 173,479
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2019 124,447
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,913
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 2,181
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 45,773
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2019 32,175
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2019 83,042
TX_RET Numerator by Status: Breastfeeding 2019 4,627
TX_RET Numerator by Status: Pregnant 2019 17,521
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2019 91,095
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 3,160
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 2,363
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 50,377
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2019 35,195
TX_RET_den Denominator by Status: Breastfeeding 2019 5,050
TX_RET_den Denominator by Status: Pregnant 2019 19,149
TX_TB Number of ART patients who were screened for TB at least once during the reporting period 2019 317,836
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Female 2019 12,714
TX_TB_den Denominator: By Aggregated Age/Sex: <15, Male 2019 9,533
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Female 2019 171,629
TX_TB_den Denominator: By Aggregated Age/Sex:15+, Male 2019 123,960
TX_TB_den Denominator: By Diagnostic Test [Subdisagg of Specimen Sent]: Gene Xpert MTB / R if Assay 2019 317,836
TX_TB_den Denominator: Number of ART patients who had a specimen sent for bacteriologic diagnosis of active TB disease 2019 317,836
TX_TB_den Life-long ART, New, TB Screen - Negative, Positive 2019 317,836
VMMC_CIRC 30-34, Male 2019 1,615
VMMC_CIRC 35-39, Male 2019 1,590
VMMC_CIRC 40-49, Male 2019 1,291
VMMC_CIRC By Age: 10-14 2019 1,614
VMMC_CIRC By Age: 15-19 2019 12,901
VMMC_CIRC By Age: 2 months - 9 years 2019 8
VMMC_CIRC By Age: 20-24 2019 7,737
VMMC_CIRC By Age: 25-29 2019 5,160
VMMC_CIRC By Age: 50+ 2019 344
VMMC_CIRC By circumcision technique: Device-based VMMC 2019 102
VMMC_CIRC By circumcision technique: Surgical VMMC 2019 32,158
VMMC_CIRC Number of males circumcised as part of the voluntary medical male circumcision (VMMC) for HIV prevention program within the reporting period 2019 32,260
VMMC_CIRC Sum of age disaggregates (FY15-Current) 2019 27,756
VMMC_CIRC Sum of age disaggregates (Prior to FY15) 2019 22,596
Cross Cutting Budget Categories and Known Amounts Total: $1,306,155
Key Populations: MSM and TG $30,000
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Key Populations: Sex Workers $50,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Condoms: Policy, Tools, and Services $25,000
Human Resources for Health $1,201,155